Prestige Consumer Healthcare Return on Tangible Equity 2010-2025 | PBH
Current and historical return on tangible equity values for Prestige Consumer Healthcare (PBH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Prestige Consumer Healthcare Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.21B | $-0.99B | -19.83% |
| 2024-12-31 | $0.21B | $-1.05B | -18.85% |
| 2024-09-30 | $0.21B | $-1.11B | -17.34% |
| 2024-06-30 | $0.21B | $-1.17B | -16.62% |
| 2024-03-31 | $0.21B | $-1.19B | -16.23% |
| 2023-12-31 | $-0.08B | $-1.26B | 6.02% |
| 2023-09-30 | $-0.08B | $-1.32B | 5.77% |
| 2023-06-30 | $-0.09B | $-1.38B | 5.67% |
| 2023-03-31 | $-0.08B | $-1.42B | 5.28% |
| 2022-12-31 | $0.21B | $-1.56B | -12.80% |
| 2022-09-30 | $0.21B | $-1.63B | -12.30% |
| 2022-06-30 | $0.20B | $-1.68B | -11.64% |
| 2022-03-31 | $0.21B | $-1.70B | -11.88% |
| 2021-12-31 | $0.19B | $-1.76B | -10.96% |
| 2021-09-30 | $0.18B | $-1.81B | -10.48% |
| 2021-06-30 | $0.18B | $-1.63B | -10.52% |
| 2021-03-31 | $0.17B | $-1.70B | -9.42% |
| 2020-12-31 | $0.17B | $-1.74B | -9.23% |
| 2020-09-30 | $0.16B | $-1.78B | -8.85% |
| 2020-06-30 | $0.15B | $-1.83B | -8.01% |
| 2020-03-31 | $0.14B | $-1.88B | -7.35% |
| 2019-12-31 | $-0.03B | $-1.91B | 1.73% |
| 2019-09-30 | $-0.03B | $-1.96B | 1.70% |
| 2019-06-30 | $-0.04B | $-1.98B | 1.76% |
| 2019-03-31 | $-0.04B | $-1.99B | 1.72% |
| 2018-12-31 | $0.06B | $-2.09B | -2.92% |
| 2018-09-30 | $0.34B | $-2.13B | -15.42% |
| 2018-06-30 | $0.34B | $-2.17B | -14.61% |
| 2018-03-31 | $0.34B | $-2.22B | -13.90% |
| 2017-12-31 | $0.39B | $-2.29B | -15.24% |
| 2017-09-30 | $0.11B | $-2.62B | -4.47% |
| 2017-06-30 | $0.11B | $-2.66B | -4.95% |
| 2017-03-31 | $0.07B | $-2.70B | -3.45% |
| 2016-12-31 | $0.07B | $-1.70B | -3.98% |
| 2016-09-30 | $0.07B | $-1.76B | -3.77% |
| 2016-06-30 | $0.07B | $-1.84B | -3.79% |
| 2016-03-31 | $0.10B | $-1.94B | -5.64% |
| 2015-12-31 | $0.11B | $-1.68B | -6.33% |
| 2015-09-30 | $0.10B | $-1.72B | -5.80% |
| 2015-06-30 | $0.09B | $-1.76B | -4.80% |
| 2015-03-31 | $0.08B | $-1.80B | -4.75% |
| 2014-12-31 | $0.07B | $-1.83B | -4.84% |
| 2014-09-30 | $0.05B | $-1.86B | -4.16% |
| 2014-06-30 | $0.07B | $-1.08B | -6.59% |
| 2014-03-31 | $0.07B | $-1.02B | -7.03% |
| 2013-12-31 | $0.08B | $-1.04B | -7.25% |
| 2013-09-30 | $0.09B | $-1.05B | -8.02% |
| 2013-06-30 | $0.07B | $-1.04B | -6.60% |
| 2013-03-31 | $0.07B | $-1.06B | -5.89% |
| 2012-12-31 | $0.05B | $-1.09B | -4.07% |
| 2012-09-30 | $0.04B | $-1.12B | -4.43% |
| 2012-06-30 | $0.04B | $-1.15B | -4.47% |
| 2012-03-31 | $0.04B | $-1.17B | -5.42% |
| 2011-12-31 | $0.04B | $-0.53B | -7.95% |
| 2011-09-30 | $0.04B | $-0.54B | -6.56% |
| 2011-06-30 | $0.03B | $-0.56B | -6.93% |
| 2011-03-31 | $0.03B | $-0.58B | -6.71% |
| 2010-12-31 | $0.03B | $-0.51B | -6.99% |
| 2010-09-30 | $0.04B | $-0.31B | -10.55% |
| 2010-06-30 | $0.03B | $-0.33B | -9.78% |
| 2010-03-31 | $0.03B | $-0.34B | -8.85% |
| 2009-12-31 | $-0.18B | $-0.35B | 48.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.123B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.835B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.40 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |